Literature DB >> 3601504

Vascular basis for neural tube defects: a hypothesis.

R E Stevenson, J C Kelly, A S Aylsworth, M C Phelan.   

Abstract

A hypothesis is set forth that neural tube defects are produced by inadequate nutrient supply to the rapidly growing neural folds. According to this hypothesis, a delay in establishing blood flow or an aberration of blood supply to neural tissue may interfere with nutrition and prevent neural tube closure. The hypothesis was tested by examining the vasculature of fetuses with spinal neural tube defects. In each case, the arterial supply to the region of the neural tube defect was disturbed. Because development of arterial supply to the neural folds predates neural tube closure, these vascular abnormalities are considered to be primary malformations that lead to neural tube defects rather than secondary morphologic disturbances resulting from neural tube defects.

Entities:  

Mesh:

Year:  1987        PMID: 3601504

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  4 in total

1.  Considering the Embryopathogenesis of VACTERL Association.

Authors:  R E Stevenson; A G W Hunter
Journal:  Mol Syndromol       Date:  2013-02

2.  The pattern of congenital renal anomalies associated with neural tube defects.

Authors:  S A Hulton; P D Thomson; L S Milner; J M Isdale; J Ling
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

3.  Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis.

Authors:  Goeril Karlsson; Gordon Francis; Gideon Koren; Peter Heining; Xiaoli Zhang; Jeffrey A Cohen; Ludwig Kappos; William Collins
Journal:  Neurology       Date:  2014-01-24       Impact factor: 9.910

4.  Methylome analysis for spina bifida shows SOX18 hypomethylation as a risk factor with evidence for a complex (epi)genetic interplay to affect neural tube development.

Authors:  Anne Rochtus; Raf Winand; Griet Laenen; Elise Vangeel; Benedetta Izzi; Christine Wittevrongel; Yves Moreau; Carla Verpoorten; Katrien Jansen; Chris Van Geet; Kathleen Freson
Journal:  Clin Epigenetics       Date:  2016-10-13       Impact factor: 6.551

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.